Edward A. Weinstein

Pfizer (United States) — United States

Medicine · Health Sciences

16h-index1.8kcitations36works3.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Long-Term Effects of COVID-19(6), Tuberculosis Research and Epidemiology(5), COVID-19 Clinical Research Studies(5), Infectious Diseases and Tuberculosis(5), Antibiotics Pharmacokinetics and Efficacy(4)

Publications36 total

P-705. Time to Testing, Diagnosis, and Hospitalization Among Pediatric and Adult Patients with RSV in Two Seasons: A Real-World Data Analysis using Electronic Health Records in the US
Open Forum Infectious Diseases·2026Open Access
Symptom Alleviation/Resolution and Returns to Usual Health/Activities in Immunocompromised Adults with COVID-19 Treated with Nirmatrelvir-Ritonavir: Results from the EPIC-IC Trial
Infectious Diseases and Therapy·2025Open Access
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity
Clinical Infectious Diseases·2025Open Access
Development and content validation of the Long COVID/ post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument
Journal of Patient-Reported Outcomes·2025Open Access
Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial
The Lancet Infectious Diseases·2025· 13 citedOpen Access
Integrated virologic analysis of resistance to nirmatrelvir/ritonavir in individuals across four phase 2/3 clinical studies for the treatment of COVID-19
EBioMedicine·2025· 5 citedOpen Access
PCR250 Burden of COVID-19 on Health-Related Quality of Life in Immunocompromised Adult Participants From the EPIC-IC Trial
Value in Health·2025
Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis
BMJ Open·2024· 15 citedOpen Access
Integrated Clinical Virologic Analysis of Resistance to Nirmatrelvir/Ritonavir Across the EPIC Randomized Controlled Trials
SSRN Electronic Journal·2024Open Access
Subphenotypes of Self-Reported Symptoms and Outcomes in Long COVID: a prospective cohort study with latent class analysis
2023Open Access
Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy
Clinical Pharmacology & Therapeutics·2022· 11 cited
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)
Clinical Infectious Diseases·2020· 47 cited
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development
Antimicrobial Agents and Chemotherapy·2020· 20 citedOpen Access
Assessing Animal Models of Bacterial Pneumonia Used in Investigational New Drug Applications for the Treatment of Bacterial Pneumonia
Antimicrobial Agents and Chemotherapy·2020· 20 citedOpen Access
Erratum for DeMarco et al., “Determination of [ <sup>11</sup> C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging”
Antimicrobial Agents and Chemotherapy·2019Open Access
Positron Emission Tomography Imaging with 2-[<sup>18</sup>F]F-<i>p</i>-Aminobenzoic Acid Detects <i>Staphylococcus aureus</i> Infections and Monitors Drug Response
ACS Infectious Diseases·2018· 84 citedOpen Access
Biodistribution and Pharmacokinetics of Antimicrobials
2017· 7 cited
A Systematic Approach for Developing Bacteria-Specific Imaging Tracers
Journal of Nuclear Medicine·2016· 103 citedOpen Access
Determination of [ <sup>11</sup> C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging
Antimicrobial Agents and Chemotherapy·2015· 47 citedOpen Access
Imaging Enterobacteriaceae infection in vivo with <sup>18</sup> F-fluorodeoxysorbitol positron emission tomography
Science Translational Medicine·2014· 220 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sanjay K. Jain(7), Alvaro A. Ordoñez(6), Vincent P. DeMarco(4), Mariah H. Klunk(4), Candace Bramson(4), Mary Lynn Baniecki(4), Shunjie Guan(4), Harvey Rubin(3), Zhuo Zhang(3), Peter J. Tonge(3), Dmitri Iarikov(3), John Farley(3), Elena Tudone(3), Jennifer Hammond(3), Joseph C. Cappelleri(3), Ruth Mokgokong(3), Takahiro Yano(2), Linsheng Li(2), David Avarbock(2), Allison M. Murawski(2)